<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03084978</url>
  </required_header>
  <id_info>
    <org_study_id>2016-7021</org_study_id>
    <nct_id>NCT03084978</nct_id>
  </id_info>
  <brief_title>Conscious Sedation vs General Anesthesia in TAVR Patients</brief_title>
  <official_title>Randomized Prospective Study in Transcatheter Aortic Valve Replacement Patients- Conscious Sedation VS. General Anesthesia Examining the Effect on Operative Time</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Montefiore Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Montefiore Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized controlled trial investigating the effect of general anesthesia versus
      conscious sedation on operative times in patients undergoing transcatheter aortic valve
      replacement.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 2017</start_date>
  <completion_date type="Anticipated">April 2019</completion_date>
  <primary_completion_date type="Anticipated">April 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time-on-table</measure>
    <time_frame>&lt;1 day</time_frame>
    <description>time to patient on table to surgical drapes down
time to patient on table to when deemed safe for transport by anesthesiologist and surgeon</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of patients with serious adverse events</measure>
    <time_frame>within 30 days</time_frame>
    <description>deaths
conversion from sedation to intubation
hypersensitivity reactions</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of stay</measure>
    <time_frame>within 30 days</time_frame>
    <description>ICU length of stay (days)
Hospital length of stay (days)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Readmissions</measure>
    <time_frame>within 30 days</time_frame>
    <description>Number of patients readmitted within 30 days of initial procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Patients with Valve Complications</measure>
    <time_frame>within 30 days</time_frame>
    <description>paravalvular leak on echocardiogram
pacemaker requirement
vascular complications requiring reintervention
post-procedure requiring valve dilation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Contrast usage</measure>
    <time_frame>&lt;1 day</time_frame>
    <description>Amount of contrast used in mL for procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fluoroscopy time</measure>
    <time_frame>&lt;1 day</time_frame>
    <description>Amount of time fluoroscopy used</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Post-procedure Complications</measure>
    <time_frame>within 30 days</time_frame>
    <description>TIA or Stroke
Myocardial Infarction
Bleeding
Infection</description>
  </other_outcome>
  <other_outcome>
    <measure>Quality of Life</measure>
    <time_frame>Procedure start to 30 days</time_frame>
    <description>Kansas City Cardiomyopathy Questionnaire at 30 days</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Aortic Stenosis</condition>
  <arm_group>
    <arm_group_label>General Anesthesia</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects will undergo general anesthesia with endotracheal intubation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conscious Sedation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will undergo conscious sedation anesthesia.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>General Anesthesia</intervention_name>
    <description>General anesthesia by standard endotracheal intubation.</description>
    <arm_group_label>General Anesthesia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Conscious Sedation</intervention_name>
    <description>Conscious sedation</description>
    <arm_group_label>Conscious Sedation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Signed informed consent, signed Health Insurance Portability and Accountability Act
             (HIPAA) documentation)

          2. Age over 18 years of age.

          3. Women of child bearing age must have a negative urine or serum pregnancy test.

          4. Clinical indication for a transfemoral aortic valve replacement.

          5. English or Spanish speaking

          6. No evidence of neurological impairment as defined by a NIHSS ≤ 1 and modified Rankin
             scale (mRS) ≤ 2 within 7 days prior to randomization.

        Exclusion Criteria:

          1. BMI &gt; 40

          2. Diagnosis of severe obstructive sleep apnea based on previous polysomnography, with
             severe defined as an apnea-hypopnea index (AHI) &gt;30 episodes/hr.

          3. High risk for aspiration such as severe esophageal disease (e.g. achalasia,
             gastroparesis, etc).

          4. Inability to lie supine for more than 30 minutes.

          5. Marginal femoral vessels with concern for possible conversion to transapical or
             transaortic access.

          6. Patient refusal

          7. Patient involved in another research study

          8. Psychiatric condition precluding ability to provide informed consent

          9. History of clinical stroke within 3 months prior to randomization
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joseph DeRose, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Montefiore Medical Center</affiliation>
  </overall_official>
  <reference>
    <citation>Brecker SJ, Bleiziffer S, Bosmans J, Gerckens U, Tamburino C, Wenaweser P, Linke A; ADVANCE Study Investigators. Impact of Anesthesia Type on Outcomes of Transcatheter Aortic Valve Implantation (from the Multicenter ADVANCE Study). Am J Cardiol. 2016 Apr 15;117(8):1332-8. doi: 10.1016/j.amjcard.2016.01.027. Epub 2016 Jan 28.</citation>
    <PMID>26892451</PMID>
  </reference>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 25, 2017</study_first_submitted>
  <study_first_submitted_qc>March 14, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 21, 2017</study_first_posted>
  <last_update_submitted>March 14, 2017</last_update_submitted>
  <last_update_submitted_qc>March 14, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 21, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Montefiore Medical Center</investigator_affiliation>
    <investigator_full_name>Joseph Derose</investigator_full_name>
    <investigator_title>Chief, Division of Cardiothoracic Surgery</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aortic Valve Stenosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

